Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
Notifications can be managed in browser preferences.
Next article
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A vaccine that appears to slow the progression of one of the most deadly cancers could be manufactured in bulk, researchers say.
The jab uses mRNA technology to train the immune system to fight cancerous cells
Researchers say they have developed a novel ‘nanoparticle-based’ jab that can prevent melanoma, pancreatic and triple-negative…
Discovery could revolutionise early identification and intervention for the deadly disease
Discovery could be ‘significant step’ towards universal cancer vaccine
Pancreatic cancer is the fifth most common cause of cancer deaths in the UK, according to the NHS
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Off-the-shelf vaccine shows promise in preventing cancers returning, study finds
Cancer vaccines to be given to patients with deadly head and neck tumours
Clinical trial shows promise for new pancreatic cancer vaccine - UPI.com
‘Tailored’ prostate cancer treatment can give men extra time
New treatment could cut lung cancer deaths by a quarter
